&nbsp;

DPM-OropharyngealPositiveTreatment.pdf

Jun 2025

Regimen

DURV(MNT)

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Drugs Used:

durvalumab (Compassionate)

Quick Link(s):

Regimen Monograph

Jun 2025

Document

Depistage-du-cancer-colorectal-print.pdf

New

Jul 2025

Regimen

DURV

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Adjuvant, Curative

Drugs Used:

durvalumab (Compassionate)

Quick Link(s):

Regimen Monograph

Sep 2025

Document

DataTablesErrata.xlsx

New

Nov 2025

Document

DataFigures-Erratta.xlsx

New

Nov 2025

Regimen

DEXAPOMA+BELA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

belantamab mafodotin (Compassionate),

pomalidomide (Unfunded),

dexamethasone

Quick Link(s):

Regimen Monograph

Nov 2025

Guidelines and Advice

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

Status: Current
ID: GL 1-22-A
Version: 2

Jul 2022

Drug

denosumab

Other Name(s): Xgeva®; Wyost™; Osenvelt™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Updated

Dec 2025

Regimen

DCTN

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

DACTINomycin